Engineered Zinc Oxide Nanoparticles; Biological Interactions at the Organ Level

Area of Science:

• Nanotechnology
• Toxicology
• Materials Science

Background:

• Zinc oxide nanoparticles (ZnO NPs) are extensively used in consumer and biomedical products.
• Increased application leads to higher occupational and consumer exposure risks.
• Existing data on ZnO NP toxicity is abundant but often contradictory.

Purpose of the Study:

• To review the interaction of ZnO NPs with various organ systems.
• To identify factors influencing ZnO NP toxicity studies.
• To improve the reliability of future research on ZnO NP biointeractions.

Main Methods:

• Literature review of in vivo studies on ZnO NP toxicity.
• Analysis of factors affecting nanoparticle toxicity: synthesis, properties, exposure route, and test systems.
• Focus on interactions with different organ systems.

Main Results:

• Toxicity of ZnO NPs is often linked to particle dissolution and reactive oxygen species generation.
• In vivo studies show varied toxicity levels across different animal models and humans.
• Discrepancies in study results are influenced by nanoparticle characteristics and experimental design.

Conclusions:

• The exact mechanism of ZnO NP toxicity requires further elucidation.
• Standardization of experimental conditions is crucial for reliable toxicity assessments.
• Understanding organ-specific interactions is key to managing ZnO NP risks.